70 related articles for article (PubMed ID: 35517415)
1. Identifying structural and dynamic changes during the Biliverdin Reductase B catalytic cycle.
Lee E; McLeod MJ; Redzic JS; Marcolin B; Thorne RE; Agarwal P; Eisenmesser EZ
Front Mol Biosci; 2023; 10():1244587. PubMed ID: 37645217
[TBL] [Abstract][Full Text] [Related]
2. Identification of prognostic biomarkers for cholangiocarcinoma by combined analysis of molecular characteristics of clinical MVI subtypes and molecular subtypes.
Li MY; Liu YH; Wei F; Zhang P; Sun XD; Wang M; Du XH; Ye JF; Qiu W; Shi XJ; Ji B; Wang YC; Jiang C; Chai WG; Huang B; Liu XK; Chen QM; Fu Y; Hu XT; Chen LG; He JX; Chai KY; Gou ZM; Yang T; Wang GY; Jiang YF; Fan ZQ; Lv GY
Genomics; 2024 Jun; 116(5):110889. PubMed ID: 38901654
[TBL] [Abstract][Full Text] [Related]
3. Low expression of RACK1 is associated with metastasis and worse prognosis in cholangiocarcinoma.
Gao Z; Sun W; Ni X; Wan W; Suo T; Ni X; Liu H; Li N; Sheng Shen ; Liu H
Heliyon; 2024 Mar; 10(6):e27366. PubMed ID: 38509930
[TBL] [Abstract][Full Text] [Related]
4. An enzyme that selectively S-nitrosylates proteins to regulate insulin signaling.
Zhou HL; Grimmett ZW; Venetos NM; Stomberski CT; Qian Z; McLaughlin PJ; Bansal PK; Zhang R; Reynolds JD; Premont RT; Stamler JS
Cell; 2023 Dec; 186(26):5812-5825.e21. PubMed ID: 38056462
[TBL] [Abstract][Full Text] [Related]
5. Metabolic Functions of Biliverdin IXβ Reductase in Redox-Regulated Hematopoietic Cell Fate.
Bahou WF; Marchenko N; Nesbitt NM
Antioxidants (Basel); 2023 May; 12(5):. PubMed ID: 37237924
[TBL] [Abstract][Full Text] [Related]
6. The novel epithelial-mesenchymal transition-related proteins and their therapeutic targets in cholangiocarcinoma: a narrative review.
Kimawaha P; Techasen A
J Gastrointest Oncol; 2023 Jun; 14(3):1593-1612. PubMed ID: 37435208
[TBL] [Abstract][Full Text] [Related]
7. Biliverdin reductase B impairs cholangiocarcinoma cell motility by inhibiting the Notch/Snail signaling pathway.
Gao Z; Ni X; Zheng B; Sun W; Wan W; Liu H; Ni X; Suo T; Li N; Liu H; Shen S
J Cancer; 2022; 13(7):2159-2170. PubMed ID: 35517415
[TBL] [Abstract][Full Text] [Related]
8. 14-3-3ζ and aPKC-ι synergistically facilitate epithelial-mesenchymal transition of cholangiocarcinoma via GSK-3β/Snail signaling pathway.
Yang Y; Liu Y; He JC; Wang JM; Schemmer P; Ma CQ; Qian YW; Yao W; Zhang J; Qi WP; Fu Y; Feng W; Yang T
Oncotarget; 2016 Aug; 7(34):55191-55210. PubMed ID: 27409422
[TBL] [Abstract][Full Text] [Related]
9. aPKC-ι/P-Sp1/Snail signaling induces epithelial-mesenchymal transition and immunosuppression in cholangiocarcinoma.
Qian Y; Yao W; Yang T; Yang Y; Liu Y; Shen Q; Zhang J; Qi W; Wang J
Hepatology; 2017 Oct; 66(4):1165-1182. PubMed ID: 28574228
[TBL] [Abstract][Full Text] [Related]
10. Extracellular vesicle-encapsulated miR-30e suppresses cholangiocarcinoma cell invasion and migration via inhibiting epithelial-mesenchymal transition.
Ota Y; Takahashi K; Otake S; Tamaki Y; Okada M; Aso K; Makino Y; Fujii S; Ota T; Haneda M
Oncotarget; 2018 Mar; 9(23):16400-16417. PubMed ID: 29662654
[TBL] [Abstract][Full Text] [Related]
11.
Nesbitt NM; Zheng X; Li Z; Manso JA; Yen WY; Malone LE; Ripoll-Rozada J; Pereira PJB; Mantle TJ; Wang J; Bahou WF
J Biol Chem; 2018 Apr; 293(15):5431-5446. PubMed ID: 29487133
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor-α (TNF-α) stimulates the epithelial-mesenchymal transition regulator Snail in cholangiocarcinoma.
Techasen A; Namwat N; Loilome W; Bungkanjana P; Khuntikeo N; Puapairoj A; Jearanaikoon P; Saya H; Yongvanit P
Med Oncol; 2012 Dec; 29(5):3083-91. PubMed ID: 22903530
[TBL] [Abstract][Full Text] [Related]
13. Bilirubin deficiency renders mice susceptible to hepatic steatosis in the absence of insulin resistance.
Chen W; Tumanov S; Fazakerley DJ; Cantley J; James DE; Dunn LL; Shaik T; Suarna C; Stocker R
Redox Biol; 2021 Nov; 47():102152. PubMed ID: 34610553
[TBL] [Abstract][Full Text] [Related]
14. Cholangiocarcinoma.
Brindley PJ; Bachini M; Ilyas SI; Khan SA; Loukas A; Sirica AE; Teh BT; Wongkham S; Gores GJ
Nat Rev Dis Primers; 2021 Sep; 7(1):65. PubMed ID: 34504109
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
